Bryan Geoffrey Morton
Fondatore presso EUSA Pharma, Inc.
Provenienza dei contatti di primo grado di Bryan Geoffrey Morton
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
EUSA Pharma, Inc.
 EUSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight products on the market, including Caphosol for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high-dose chemotherapy, ProstaScint for imaging the extent and spread of prostate cancer, Quadramet for the treatment of pain in patients whose cancer has spread to the bones, Erwinase and Kidrolase for the treatment of acute lymphoblastic leukemia and the antibiotic surgical implant Collatamp. EUSA also has several products in late-stage development, notably Collatamp topical, a gentamicin impregnated collagen sponge for the prevention and treatment of infected skin ulcers, and CollaRx bupivacaine implant for local post-surgical pain control. Founded in 2006, EUSA Pharma is supported by a consortium of leading life science capital investors, comprising TVM Capital, Essex Woodlands, 3i, Goldman Sachs, Advent Venture Partners, SV Life Sciences, NeoMed and NovaQuest. Since its foundation, the company has raised over $275 million, and completed several significant transactions, including the acquisitions of Cytogen Corporation, Talisker Pharma Ltd, the French biopharmaceutical company OPi SA and the European antibiotic and pain control business of Innocoll Pharmaceuticals Inc. As part of its rapid growth strategy the company has established commercial infrastructure in the US, a pan-European presence covering over 20 countries and a wider distribution network in a further 25 territories. EUSA Pharma plans to continue its aggressive program of acquisitions and in-licensing within its specialist areas of medical and geographic focus, in line with its ambitious target to create a rapidly growing $1 billion company by the beginning of the next decade.
17
| Subsidiary | Pharmaceuticals: Major | 17 |
Essex Woodlands Management, Inc.
 Essex Woodlands Management, Inc. Investment ManagersFinance Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas.
15
| Private Company | Investment Managers | 15 |
| Public Company | Pharmaceuticals: Major | 10 | |
EUSA Pharma (UK) Ltd.
 EUSA Pharma (UK) Ltd. Medical DistributorsDistribution Services EUSA Pharma (UK) Ltd. supplies medicines and medical devices. It offers Caphosol, Xenazine, Collatamp, Custodiol, and Fomepizole. The company was founded in March 2015 and is headquartered in Hemel Hempstead, the United Kingdom.
8
| Subsidiary | Medical Distributors | 8 |
EUSA Pharma SAS
 EUSA Pharma SAS BiotechnologyHealth Technology EUSA Pharma SAS specializes in pharmaceutical research for rare diseases. The company was founded by Gilles Alberici on September 24, 1999 and is headquartered in Limonest, France.
5
| Subsidiary | Biotechnology | 5 |
| Private Company | Pharmaceuticals: Major | 4 | |
Zeneus Pharma Ltd.
 Zeneus Pharma Ltd. Medical DistributorsDistribution Services Zeneus Pharma Ltd. provides pharmaceutical products. It offers license to late-stage development, pre and post-approval, and marketing services across Europe for specialty hospital medicines. The company was founded in 2004 by Bryan Morton and is headquartered in Oxford, UK.
3
| Subsidiary | Medical Distributors | 3 |
Essex Woodlands Health Ventures UK Ltd.
2
| Subsidiary | Investment Managers | 2 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Bryan Geoffrey Morton tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal | |
| 3I GROUP PLC | Investment Managers | Corporate Officer/Principal Director of Finance/CFO | |
The Chartered Governance Institute
 The Chartered Governance Institute Miscellaneous Commercial ServicesCommercial Services The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Circassia Ltd.
 Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
White Pine Medical, Inc.
 White Pine Medical, Inc. Medical SpecialtiesHealth Technology White Pine Medical, Inc. manufactures and markets medical devices. The company was founded in February 2010 and is headquartered in Park City, UT. | Medical Specialties | Chairman Director/Board Member | |
EW Healthcare Partners Fund
 EW Healthcare Partners Fund Investment ManagersFinance EW Healthcare Partners Fund seeks investment opportunities in middle market companies located in the United States, Europe, Latin America, and China with revenues of USD 20 to USD 200 million. It targets companies operating in the fields of pharmaceuticals, medical devices, healthcare services, and healthcare IT. It provides financing for growth capital requirements with an investment size ranging from USD 20 to USD 80 million and invest up to USD 100 million. It also acquires minority and majority interest. | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal Consultant / Advisor | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Undergraduate Degree | |
| Stanford University | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| University of Pennsylvania | College/University | Masters Business Admin Doctorate Degree | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | General Counsel Director/Board Member | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Director of Finance/CFO | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree | |
| Imperial College London | College/University | Undergraduate Degree Graduate Degree | |
Institute of Chartered Accountants in England & Wales
 Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Wellcome Plc
 Wellcome Plc Miscellaneous Commercial ServicesCommercial Services Part of GSK Plc, Wellcome Plc is a British company that specializes in the discovery, development, manufacture, and sale of human healthcare products. The company is based in Greenford, UK. | Miscellaneous Commercial Services | Director/Board Member Sales & Marketing | |
| EYEPOINT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Simbec Research Ltd.
 Simbec Research Ltd. Miscellaneous Commercial ServicesCommercial Services Simbec Research Ltd. provides clinical research service to pharmaceutical and biotechnology industries. It conducts drug trails for allergy, anti-infectives, cardiovascular, gastrointestinal, anti-inflammatory, oncology and respiratory. The firm also offers consultancy services, preparation of marketing authorization applications, and clinical trial applications. The company was founded in 1976 and is headquartered in Merthyr Tydfil, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| Amherst College | College/University | Undergraduate Degree Undergraduate Degree | |
| University of London | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Biotechnology | Chairman Director/Board Member Director/Board Member Director/Board Member | |
ProteinSimple
 ProteinSimple Medical SpecialtiesHealth Technology ProteinSimple engages in the proprietary systems and consumables for protein analysis. Its products include simple plex, ice, simple western, micro-flow imaging, and single-cell western. The company was founded by Linda Cahill, Nancy Allbritton, Christopher Sims, Scott Lockard, and Jim Schlater in December 2000 and is headquartered in San Jose, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
ReNeuron Ltd.
 ReNeuron Ltd. BiotechnologyHealth Technology ReNeuron Ltd. researches and develops drugs, diagnostics, and other therapeutic products. The company was founded on May 23, 1997 and is headquartered in Bridgend, the United Kingdom. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
| London Business School | College/University | Masters Business Admin Corporate Officer/Principal | |
| CORIUM INTERNATIONAL INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman | |
| King's College London | College/University | Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member Director/Board Member | |
Clear Vascular, Inc.
 Clear Vascular, Inc. Pharmaceuticals: MajorHealth Technology Clear Vascular, Inc. develops radionuclide products for multiple clinical applications. The firm has developed an injectable, targeted radiopharmaceutical agent, Tin-Annexin, for imaging and therapy of inflammatory tissues, initially targeting vulnerable and unstable plaque. It is a private radiopharmaceutical company developing a unique radionuclide for multiple clinical applications including diagnosis and therapy. The company was founded by Gilbert R. Gonzales in 2005 and is headquartered in Austin, TX. | Pharmaceuticals: Major | President Director/Board Member | |
Cirtec Medical Systems LLC
 Cirtec Medical Systems LLC Medical SpecialtiesHealth Technology Cirtec Medical Systems LLC provides outsourced design and manufacturing services for neuro-stimulation and cardiovascular devices. Its services include products management, design and development, device assemble and product transfers. The company was founded by Laurence S. Derose, Merwin Jerry Hansen and Michael Forman in 2009 and is headquartered in Los Gatos, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Jazz Pharmaceuticals UK Ltd.
 Jazz Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals UK Ltd. is pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, oncology supportive care and critical care products. The company was founded in 2006 and is headquartered in Oxford, United Kingdom. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Director of Finance/CFO General Counsel Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
| AXOGEN, INC. | Medical Specialties | Director/Board Member Director/Board Member | |
| Richards Underwriting Ltd. | Director/Board Member | ||
| BIOVENTUS INC. | Medical Specialties | Chairman Director/Board Member Director/Board Member | |
| NIOX GROUP PLC | Medical/Nursing Services | Director/Board Member Founder | |
Ellipses Pharma Ltd.
 Ellipses Pharma Ltd. Pharmaceuticals: MajorHealth Technology Ellipses Pharma Ltd. engages in the development of cancer medicines and treatment drugs. The company was founded by Christopher Evans and Rajan Jethwa in April 14, 2015 and is headquartered in London, the United Kingdom. | Pharmaceuticals: Major | Founder Director of Finance/CFO | |
Simbec-Orion Group Ltd.
 Simbec-Orion Group Ltd. Pharmaceuticals: MajorHealth Technology Simbec-Orion Group Ltd. provides contract research services for rare and orphan conditions. The firm offers services for oncology, orphan diseases, respiratory, dermatology, infectious vaccines and diseases. The company was founded in 2014 and is headquartered in Pentrebach, the United Kingdom. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Arix Capital Management Ltd.
 Arix Capital Management Ltd. Investment ManagersFinance Arix Capital Management Ltd (Arix Capital Management) is a venture capital subsidiary of Arix Bioscience Plc founded in 2012 by Christopher Thomas Evans. The firm is headquartered in Cardiff, United Kingdom. | Investment Managers | Director/Board Member Founder | |
EDX Medical Group Plc
 EDX Medical Group Plc Medical/Nursing ServicesHealth Services EDX Medical Group Plc engages in the provision of medical goods in the United Kingdom. It distributes Guardant Health’s cancer genomic tests for healthcare providers in Sweden, Denmark, Norway, Finland and Iceland (Nordics), also serving the private healthcare sector in the United Kingdom. The company was founded by Christopher Thomas Evans and Michael Hudson John on March 19, 2021 and is headquartered in Cambridge, the United Kingdom. | Medical/Nursing Services | Director/Board Member Founder | |
EDX Medical Ltd.
 EDX Medical Ltd. Medical/Nursing ServicesHealth Services Part of EDX Medical Group Plc, EDX Medical Ltd. is a British company that operates as a digital diagnostics. The company is based in Cambridge, UK. The company was founded by Christopher Thomas Evans. The CEO is Michael John Hudson. EDX Medical was acquired by TECC Capital Plc on November 14, 2022 for $6.88 million. | Medical/Nursing Services | Director/Board Member Founder | |
Encore Dermatology, Inc.
 Encore Dermatology, Inc. Medical SpecialtiesHealth Technology Encore Dermatology, Inc. manufactures prescription therapies and medical devices for dermatologists. It offers hylatopicplus emollient foam, hylatopicplus cream, and tetrix cream to manage and relieve the burning, itching, and pain. The company was founded Robert J. Moccia and Michael Brown in 2015 and is headquartered in Malvern, PA. | Medical Specialties | Founder Director/Board Member | |
Alliance Pharmaceuticals Ltd. (United Kingdom)
 Alliance Pharmaceuticals Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Alliance Pharma Plc, Alliance Pharmaceuticals Ltd. is a British UK-based company founded in 1996 by John Dawson. The company is an international consumer healthcare business that offers trusted and proven brands to improve people's health and wellbeing. The company has a consistent track record of investing in both organic growth and acquisitions. The company works with a team of people, brands, and partners to achieve more for patients, healthcare providers, business partners, and investors. Peter Jonathan Butterfield has been the CEO of the company since 2010. | Pharmaceuticals: Major | Chairman |
Statistiche
Distribuzione geografica
| Regno Unito | 25 |
| Stati Uniti | 22 |
| Finlandia | 2 |
| Australia | 2 |
| Danimarca | 2 |
Settori
| Health Technology | 30 |
| Consumer Services | 10 |
| Commercial Services | 5 |
| Finance | 4 |
| Health Services | 4 |
Posizioni
| Director/Board Member | 379 |
| Chairman | 100 |
| Corporate Officer/Principal | 100 |
| Independent Dir/Board Member | 72 |
| Chief Executive Officer | 48 |
Contatti più connessi
| Insiders | |
|---|---|
| Christopher Evans | 62 |
| William Hawkins | 49 |
| Göran Albert Ando | 44 |
| Simon Cartmell | 39 |
| Trevor Jones | 36 |
| William W. Crouse | 29 |
| Guido Neels | 25 |
| John Berriman | 24 |
| Ronald Eastman | 24 |
| Chris Richards | 24 |
| Jeff Himawan | 24 |
| Petri T. Vainio | 24 |
| Timothy Corn | 20 |
| Ian Lobley | 19 |
| Gilles Alberici | 18 |
- Borsa valori
- Insiders
- Bryan Geoffrey Morton
- Connessioni Società
